For: | Yi J, Wang ZW, Cang H, Chen YY, Zhao R, Yu BM, Tang XM. p16 gene methylation in colorectal cancers associated with Duke′s staging. World J Gastroenterol 2001; 7(5): 722-725 [PMID: 11819863 DOI: 10.3748/wjg.v7.i5.722] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v7/i5/722.htm |
Number | Citing Articles |
1 |
Partha M. Das, Rakesh Singal. DNA Methylation and Cancer. Journal of Clinical Oncology 2004; 22(22): 4632 doi: 10.1200/JCO.2004.07.151
|
2 |
Dor Mohammad Kordi-Tamandani, Mohammad Ayub Rigi Ladies, Mohammad Hashemi, Abdul-Karim Moazeni-Roodi, Smriti Krishna, Adam Torkamanzehi. Analysis of p15 INK4b and p16 INK4a Gene Methylation in Patients with Oral Squamous Cell Carcinoma. Biochemical Genetics 2012; 50(5-6): 448 doi: 10.1007/s10528-011-9489-6
|
3 |
Maria Pufulete, Peter W. Emery, Thomas A. B. Sanders. Folate, DNA methylation and colo-rectal cancer. Proceedings of the Nutrition Society 2003; 62(2): 437 doi: 10.1079/PNS2003265
|
4 |
Ning Zhou, Quankai Gu. Prognostic and clinicopathological value of p16 protein aberrant expression in colorectal cancer. Medicine 2018; 97(12): e0195 doi: 10.1097/MD.0000000000010195
|
5 |
Hiroyuki Mitomi, Naoshi Fukui, Nobuho Tanaka, Hideki Kanazawa, Tsuyoshi Saito, Takashi Matsuoka, Takashi Yao. Aberrant p16INK4a methylation is a frequent event in colorectal cancers: prognostic value and relation to mRNA expression and immunoreactivity. Journal of Cancer Research and Clinical Oncology 2010; 136(2): 323 doi: 10.1007/s00432-009-0688-z
|
6 |
Chai-Jin Lee, Jared Evans, Kwangsoo Kim, Heejoon Chae, Sun Kim. Gene Function Analysis. Methods in Molecular Biology 2014; 1101: 161 doi: 10.1007/978-1-62703-721-1_9
|
7 |
N. Ramírez, E. Bandrés, A. Navarro, A. Pons, S. Jansa, I. Moreno, F. Martínez-Rodenas, R. Zárate, N. Bitarte, M. Monzó, J. García-Foncillas. Epigenetic events in normal colonic mucosa surrounding colorectal cancer lesions. European Journal of Cancer 2008; 44(17): 2689 doi: 10.1016/j.ejca.2008.09.004
|
8 |
Valérie Boige, David Malka, Julien Taïeb, Jean-Pierre Pignon, Michel Ducreux. Cancer colorectal : altérations moléculaires pronostiques. Gastroentérologie Clinique et Biologique 2004; 28(1): 21 doi: 10.1016/S0399-8320(04)94836-1
|
9 |
Manju L. Prasad, Snehal G. Patel, Jatin P. Shah, Stacy Hoshaw-Woodard, Klaus J. Busam. Prognostic Significance of Regulators of Cell Cycle and Apoptosis, p16INK4a, p53, and bcl-2 in Primary Mucosal Melanomas of the Head and Neck. Head and Neck Pathology 2012; 6(2): 184 doi: 10.1007/s12105-011-0319-2
|
10 |
Medha Sugara, Ramachandra Chowdappa, K. V. Veerendra Kumar, Ramesh Gawari, Shalini N. Swamy, Sandeep S. Kumar. Aberrant Promoter Hypermethylation of p16 and RASSF1a Genes in Colorectal Cancer – Significance in Young Patients. Indian Journal of Surgical Oncology 2021; 12(3): 454 doi: 10.1007/s13193-021-01325-5
|
11 |
Asahiro Morishita, Tsutomu Masaki, Hitoshi Yoshiji, Seiji Nakai, Tomohiro Ogi, Yoshiaki Miyauchi, Shuhei Yoshida, Toshiharu Funaki, Naohito Uchida, Yuko Kita, Fumi Funakoshi, Hisashi Usuki, Setsuo Okada, Kunihiko Izuishi, Seishiro Watanabe, Kazutaka Kurokohchi, Shigeki Kuriyama. Reduced expression of cell cycle regulator p18INK4C in human hepatocellular carcinoma. Hepatology 2004; 40(3): 677 doi: 10.1002/hep.20337
|
12 |
Shingo Kamoshida, Hiroshi Matsuoka, Kazuya Shiogama, Atsuji Matsuyama, Ryoichi Shimomura, Ken‐ichi Inada, Morito Maruta, Yutaka Tsutsumi. Immunohistochemical analysis of thymidylate synthase, p16INK4a, cyclin‐dependent kinase 4 and cyclin D1 in colorectal cancers receiving preoperative chemotherapy: Significance of p16INK4a‐mediated cellular arrest as an indicator of chemosensitivity to 5‐fluorouracil. Pathology International 2004; 54(8): 564 doi: 10.1111/j.1440-1827.2004.01665.x
|
13 |
E Miranda, A Destro, A Malesci, E Balladore, P Bianchi, E Baryshnikova, G Franchi, E Morenghi, L Laghi, L Gennari, M Roncalli. Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer. British Journal of Cancer 2006; 95(8): 1101 doi: 10.1038/sj.bjc.6603337
|
14 |
Sannidhi Bhootra, Nandana Jill, Geetha Shanmugam, Sudeshna Rakshit, Koustav Sarkar. DNA methylation and cancer: transcriptional regulation, prognostic, and therapeutic perspective. Medical Oncology 2023; 40(2) doi: 10.1007/s12032-022-01943-1
|
15 |
Imen Miladi-Abdennadher, Rania Abdelmaksoud-Damak, Lobna Ayadi, Abdelmajid Khabir, Foued Frikha, Lamia Kallel, Mounir Frikha, Tahia Sellami-Boudawara, Ali Gargouri, Raja Mokdad-Gargouri. Aberrant methylation of hMLH1 and p16INK4a in Tunisian patients with sporadic colorectal adenocarcinoma. Bioscience Reports 2011; 31(4): 257 doi: 10.1042/BSR20100023
|
16 |
H Judson, A Stewart, A Leslie, NR Pratt, DU Baty, RJC Steele, FA Carey. Relationship between point gene mutation, chromosomal abnormality, and tumour suppressor gene methylation status in colorectal adenomas. The Journal of Pathology 2006; 210(3): 344 doi: 10.1002/path.2044
|
17 |
Yan-Zhi Chen, Dan Liu, Yu-Xia Zhao, He-Tong Wang, Ya Gao, Ying Chen. Relationships Betweenp16Gene Promoter Methylation and Clinicopathologic Features of Colorectal Cancer: A Meta-Analysis of 27 Cohort Studies. DNA and Cell Biology 2014; 33(10): 729 doi: 10.1089/dna.2013.2253
|
18 |
Carolina Haefliger, Sabine Maier, Alexander Olek. DNA Methylation and Cancer Therapy. Medical Intelligence Unit 2005; : 117 doi: 10.1007/0-387-27443-X_9
|
19 |
Yi Ding, Xiao-Ping Le, Qin-Xian Zhang, Peng Du. Methylation and mutation analysis of <italic>p16</italic> gene in gastric cancer. World Journal of Gastroenterology 2003; 9(3): 423-426 doi: 10.3748/wjg.v9.i3.423
|
20 |
Wenrui Ye, Stefan Siwko, Robert Y. L. Tsai. Sex and Race-Related DNA Methylation Changes in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(8): 3820 doi: 10.3390/ijms22083820
|
21 |
Semra Demokan, Alice Chuang, Yusufhan Suoğlu, Murat Ulusan, Zubeyde Yalnız, Joseph A. Califano, Nejat Dalay. Promoter methylation and loss of p16INK4a gene expression in head and neck cancer. Head & Neck 2012; 34(10): 1470 doi: 10.1002/hed.21949
|
22 |
Ke-Jun Nan, Hai-Xia Qin, Guang Yang. Prognostic factors in 165 elderly colorectal cancer patients. World Journal of Gastroenterology 2003; 9(10): 2207-2210 doi: 10.3748/wjg.v9.i10.2207
|
23 |
James G Herman. Hypermethylation pathways to colorectal cancer. Gastroenterology Clinics of North America 2002; 31(4): 945 doi: 10.1016/S0889-8553(02)00058-4
|
24 |
Laurent Peyrin-Biroulet, Hélène Barraud, David Ancel, Fabien Petit-Laurent, Marc-André Bigard, Jean-Louis Gueant, Jean-Pierre Bronowicki. Métabolisme des folates et cancérogenèse colorectale. Gastroentérologie Clinique et Biologique 2004; 28(6-7): 582 doi: 10.1016/S0399-8320(04)95015-4
|
25 |
A. SYED SAMEER, SAFIYA ABDULLAH, SANIYA NISSAR, ROOHI RASOOL, ZAFFAR A. SHAH, DIL AFROZE, NISSAR A. CHOWDRI, MUSHTAQ A. SIDDIQI. The blues of P(16)INK(4a): Aberrant promoter methylation and association with colorectal cancer in the Kashmir valley. Molecular Medicine Reports 2012; 5(4): 1053 doi: 10.3892/mmr.2012.740
|
26 |
Jian-Zhao Huang, Sui-Sheng Xia, Qi-Fa Ye, Han-Ying Jiang, Zhong-Hua Chen. Effects of <i>p</i>16 gene on biological behavious in hepatocellular carcimoma cells. World Journal of Gastroenterology 2003; 9(1): 84-88 doi: 10.3748/wjg.v9.i1.84
|
27 |
Lian-Xin Liu, Wei-Hui Zhang, Hong-Chi Jiang, An-Long Zhu, Lin-Feng Wu, Shu-Yi Qi, Da-Xun Piao. Arterial chemotherapy of 5-fluorouracil and mitomycin C in the treatment of liver metastases of colorectal cancer. World Journal of Gastroenterology 2002; 8(4): 663-667 doi: 10.3748/wjg.v8.i4.663
|